January 29, 2015 9:55 AM ET


Company Overview of Regenion GmbH

Company Overview

Regenion GmbH develops a drug based on antisense molecules for the treatment of neurodegenerative diseases. The company is based in Appenzell, Switzerland.

Rütistrasse 20

Appenzell,  9050


Key Executives for Regenion GmbH

Regenion GmbH does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Clinuvel AG Europe
ACIC Europe Limited Europe
Iroko Cardio International Sàrl Europe
Debiopharm S.A. Europe
Similasan AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Regenion GmbH, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.